Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare... ✔ NOT-TR-25-008 05/05/2025 Notice of Information
Notice of Rare Diseases Clinical Research Network Alumni Site: Data Storage and Access ✔ NOT-TR-25-012 07/21/2025 Notice of Information
Notice of Extension and Change for PAR-23-268 "Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) ... ✔ NOT-TR-25-007 06/06/2025 Notice of Change to Funding Opportunity
Notice of Change to Application Due Dates for PAR-25-438, "Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research N... ✔ NOT-TR-25-010 06/17/2025 Notice of Change to Funding Opportunity
Notice of Extension for PAR-25-157 Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) ✔ NOT-TR-25-009 06/05/2025 Notice of Change to Funding Opportunity
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) ✔ PAR-25-438 U54 06/06/2025 10/16/2025 NA
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) ✔ PAR-25-442 R21 06/17/2025 02/17/2028 NA
Request for Information (RFI): Better Tools to Predict Toxicities Resulting from Oligonucleotide Therapeutics ✔ NOT-TR-25-011 06/12/2025 Request for Information
Notice of Announcement of the NCATS Rare Diseases Are Not Rare! 2025 Challenge Prize Competition ✔ NOT-TR-25-014 07/30/2025 Notice of Information
Notice of Extension and Change for PAR-23-267 "Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 C... ✔ NOT-TR-25-005 06/06/2025 Notice of Change to Funding Opportunity
Showing Row 11 to 20 of 422

Last updated on February 11, 2026